Standardized Concentrations Needed For Pediatric Cough/Cold Safety – CDER
This article was originally published in The Tan Sheet
Executive Summary
Standardizing the concentrations of ingredients in OTC cough/cold products would help reduce confusion between formulations for children and those for infants, FDA's Center for Drug Evaluation and Research recommends
You may also be interested in...
Pediatric Cough/Cold OTC Safety Review Continues With Joint Panel Planned
FDA does not go far enough with its recent public health advisory on pediatric cough/cold OTCs to address the potential severe adverse events described in a citizen petition recommending labeling changes to the products, according to one of the petitioners
Vaccination Health Next Stop For Dentovations’ Self+ Immunity Supplement Line
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.
Biotin And ‘Healthy Hair’: Federal Pre-emption Clips False Advertising Complaint In California
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: